SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-325587
Filing Date
2018-11-13
Accepted
2018-11-13 17:00:11
Documents
79
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d607542d10q.htm 10-Q 796763
2 EX-31.1 d607542dex311.htm EX-31.1 11052
3 EX-31.2 d607542dex312.htm EX-31.2 11032
4 EX-32.1 d607542dex321.htm EX-32.1 4314
5 EX-32.2 d607542dex322.htm EX-32.2 4700
  Complete submission text file 0001193125-18-325587.txt   4721269

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alt-20180930.xml EX-101.INS 704883
7 XBRL TAXONOMY EXTENSION SCHEMA alt-20180930.xsd EX-101.SCH 57840
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20180930_cal.xml EX-101.CAL 87033
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20180930_def.xml EX-101.DEF 269188
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20180930_lab.xml EX-101.LAB 500430
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20180930_pre.xml EX-101.PRE 367161
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 181178862
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1